In the absence of intervention, the rate of vertical transmission of HIV
can range from 15-45%. With the inclusion of antiretroviral drugs during pregnancy
and the choice of delivery route this amounts to less than 2%. However ARV use during
pregnancy has generated several questions regarding the adverse effects of the
gestational and neonatal outcome. This study aims to analyze the risk factors for
vertical transmission of HIV-1 seropositive pregnant women living in Rio Grande and
the influence of the use of ARVs in pregnancy outcome. Among the 262 pregnant women
studied the rate of vertical transmission of HIV was found to be 3.8%. Regarding the
VT, there was a lower risk of transmission when antiretroviral drugs were used and
prenatal care was conducted at the referral service. However, the use of ART did not
influence the outcome of pregnancy. However, initiation of prenatal care after the
first trimester had an influence on low birth weight, as well as performance of less
than six visits increased the risk of prematurity. Therefore, the risk factors
analyzed in this study appear to be related to the realization of inadequate
pre-natal and maternal behavior.
Hepatitis C (HCV) is a serious public health issue, and it is estimated that 3% of the world’s population is infected. Patients in hemodialysis units have an increased risk for contracting HCV, and high prevalence rates have been found in hemodialysis units around the world. This study is aimed at determining the prevalence of HCV in patients with terminal chronic renal disease (tCRD) who have been submitted to hemodialysis and peritoneal dialysis in southern Brazil to characterize the most prevalent genotypes, the viral load, and possible risk factors and to assess the validity between the ELISA and RT-PCR detection methods. Of 320 patients from three dialysis units, 318 participated in this study. According to the medical records, 55 patients were reactive to HCV, as determined via ELISA. All 318 samples were submitted to RT-PCR and genotyped using an Abbott Realtime® m2000 system. Data obtained through a questionnaire and chemical variables were associated with the HCV. Results: The prevalence of HCV was 18.24% (58), and the concordance between the HCV serology and the RT-PCR was 94%. Three patients were diagnosed to be negative for HCV using the ELISA assay but positive when using RT-PCR. Genotype 1 was the most prevalent (46.7%) genotype, within which subtype 1a was the most frequent (74.1%). One of the risk factors associated with HCV infection was the length of time that the patient had been undergoing hemodialysis treatments (p < 0.001). Additionally, the viral load was found to vary when tested before and after hemodialysis (p < 0.001). Conclusion: The prevalence of HCV in dialysis units continues to remain high, indicating nosocomial contamination. RT-PCR detected the presence of the hepatitis C virus in patients with a non-reactive serology, which highlights the importance of performing molecular tests on dialysis patients. The variation in the viral load in patients submitted to hemodialysis indicates a possible destruction or gripping of viral particles to the dialyzer membrane.Electronic supplementary materialThe online version of this article (doi:10.1186/s12985-015-0238-z) contains supplementary material, which is available to authorized users.
It was observed a decrease in the rate of vertical transmission in recent years. According to the studied variables, is suggested that the risk factors for vertical transmission of HIV-1 were absence of antiretroviral therapy, high viral load in the pregnant women, and membrane rupture time >4h.
Prenatal care could protect against vertical transmission of HPgV among women infected with HIV; however, studies among HIV-negative individuals are still required to verify this correlation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.